New Study to Get More Minorities Involved in Genetic Testing
826 articles
Testing a New Approach to Treating Advanced Pancreatic Cancer
Scientists are testing a new drug that is an antagonist of stress hormone receptors, in combination with nab-paclitaxel, for advanced pancreatic cancer.
Targeting Mutant KRAS with Immunotherapy
Dr. Beatriz Carreno explains how her team is targeting the KRAS mutation with a pancreatic cancer vaccine to make the immune system work against cancer.
A Second Opinion Leads to Hope for the Future
Leanne Pierce decided to go to a major cancer center for a second opinion after her pancreatic cancer diagnosis.
At the Table: Anxiety Before Each Chemotherapy Treatment
Read this roundtable discussion with pancreatic cancer patients and survivors as they share insights into how they manage their anxiety around treatment.
Don’t Stop Fighting
Leonora Kaufmann relied on her instinct about pancreatic cancer. Diagnosis at stage I has given her a fighting chance of survival.
No Time to Wait: UK Pancreatic Cancer Patients Struggle with Treatment and Diagnostic Delays
Peter De Rosa of Pancreatic Cancer UK provides an update on how the COVID-19 pandemic has impacted pancreatic cancer patients in the UK.
Synergy with Metronomic Chemotherapy
Oncologists are trying metronomic chemotherapy, lower doses of toxic drugs given on a steady basis, to fight pancreatic cancer.
Immunotherapy Treatments Provide Hope to Pancreatic Cancer Patients
Dr. Robert Vonderheide of the Abramson Cancer Center at the University of Pennsylvania describes immunotherapy trials for pancreatic cancer.
Education, Clinical Trials, and Advocacy
Pat Theobald lost her mother to pancreatic cancer, so when she received the same diagnosis she knew to start treatment with a clinical trial.
Long-Term Survival After Grueling Radiation Treatment
Long-term pancreatic cancer survivor Steven Yedwabnick endured a long protocol of radiation and chemotherapy after a Whipple surgery.
Low-Dose Continuous Chemotherapy as Part of a New Combination of Drugs
A clinical trial uses a new immunotherapy drug in combination with standard chemotherapy drugs in metronomic therapy to treat metastatic pancreatic cancer.
A New Combination Targeting the RAS Pathway
Researchers are testing two new drugs that target the RAS pathway, to make standard chemotherapy more effective.
Diagnosing Pancreatic Cancer: Tests to Expect
What can you expect during pancreatic cancer diagnostic testing? Dr. Gobind Anand offers expert guidance to stay informed throughout the process.
The Relatively New Procedure of Irreversible Electroporation Has Given Me Time
When chemotherapy and radiation stopped working, Leslie Wineberg was glad to qualify for irreversible electroporation (IRE).
Let’s Win Receives Biden Cancer Initiative FIERCE Award
Let’s Win! Pancreatic Cancer Foundation is the inaugural winner of the Biden Cancer Initiative FIERCE Award for “Leadership through Exemplary and Awesome Purpose (LEAP).”